Track topics on Twitter Track topics that are important to you
AMAG Pharmaceuticals said today it has agreed to acquire Perosphere Pharmaceuticals for up to $415 million, in a deal that the buyer said will expand its pipeline, and especially its presence in hematology with Perosphere’s next-generation anticoagulant reversal candidate ciraparantag (PER977). Ciraparantag is an intravenously-administered synthetic small molecule anticoagulant reversal agent that according to Perosphere […]
The post AMAG Pharmaceuticals to Acquire Perosphere Pharmaceuticals appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: AMAG Pharmaceuticals to Acquire Perosphere PharmaceuticalsNEXT ARTICLE
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...